Biography

Dr. Thakur Gurjeet Singh is currently working as Associate Professor and Head of Department at Chitkara College of Pharmacy, Chitkara University, Rajpura, India. He obtained his Ph.D. in Pharmaceutical Sciences from same University. His professional experience includes worked as Production Chemist in Rhydburg Pharmaceuticals Ltd, Kundli, Sonepat, Lecturer at Punjab College of Technical Education, Institute of Pharmacy, Ludhiana, Punjab, and SUS College of Pharmacy, Tangori, Mohali, Punjab, and Lecturer and Assistant Professor at Chitkara College of Pharmacy, Rajpura, Punjab Technical University. He successfully guided 17 M.Pharm research students. Presently he is supervising 2 PhD students’ research projects. He is registered member of Society of Pharmaceutical Education & Research, Pharmacist of Punjab Pharmacy Council, and member of Institutional Animal Ethics Committee (IAEC) of Chitkara University. His area of research interest focuses on Research and Development, Preclinical Studies and Clinical (CRO and Pharmacovigilance, Pharma KPO), Drug Regulatory Affairs. He has published 1 book, and 5 book chapters, and 22 research articles in journals as author/co-author. He successfully completed 5 projects as Principal Investigator and Co-Investigator. He is also serving as member of editorial board and reviewer for journals. He presented various research posters/slide presentations at various National/International conferences. He also received 4 best paper presentations awards. He also attended number of conferences and symposium.

Area of Interest:

Pharmacology and Toxicology

100%

Pharmacovigilance

62%

Drug Regulatory Affair

90%

Neurodegenerative Disorders

75%

Histopathology

55%

Research Publications in Numbers

Books
0

Chapters
0

Articles
0

Abstracts
0

Selected Publications

Singh, T.G., S. Dhiman and A.K. Rehni, 2015. Nanocarriers as Nanomedicine: A Promising Platform for Drug Delivery in Nanopharmaceuticals. In: CRC Concise Encyclopedia of Nanotechnology, Kharisov, B.I., O.V. Kharissova and U. Ortiz-Mendez (Eds.). CRC Press, Boca Raton, FL., USA., ISBN-13: 978-1466580343.
Dhiman, S., T.G. Singh, A. Asthana and S. Arora, 2015. Nanosuspension: An Emerging and promising Approaches in Drug Delivery System for Bioavailability Enhancement of Poorly Soluble Drugs. In: CRC Concise Encyclopedia of Nanotechnology, Kharisov, B.I., O.V. Kharissova and U. Ortiz-Mendez (Eds.). CRC Press, Boca Raton, FL., USA., ISBN-13: 978-1466580343.
Singh, T.G., S. Sharma and S. Dhiman, 2014. Amyotrophic Lateral Sclerosis-Motor Neuron Disease: An Insight: Amyotrophic Lateral Sclerosis: Molecular Neurobiology, Emerging Concepts and Novel Therapeutic Targets. LAMBERT Academic Publishing, Germany, ISBN-13: 978-3659614248, Pages: 128.
Direct Link |
Panghal, D., M. Nagpal, G.S. Thakur and S. Arora, 2014. Dissolution improvement of atorvastatin calcium using modified locust bean gum by the solid dispersion technique. Scientia Pharmaceutica, 82: 177-191.
CrossRef | Direct Link |
Singh, T.G., S. Dhiman and A.K. Rehni, 2013. Formulation and Evaluation of Nanopharmaceuticals in Drug Delivery. In: Therapeutic Delivery Methods: A Concise Overview of Emerging Areas, Lee, B.J. (Ed.). Future Science Ltd., London, UK., ISBN-13: 9781909453494, pp: 80-95.
Singh, T.G., A.K. Rehni and S.K. Arora, 2013. Pharmacological modulation of farnesyltransferase subtype I attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice. Behav. Pharmacol., 24: 668-677.
CrossRef | PubMed | Direct Link |
Rehni, A.K. and T.G. Singh, 2013. Selenium induced anticonvulsant effect: A potential role of prostaglandin E₁ receptor activation linked mechanism. J. Trace Elem. Med. Biol., 27: 31-39.
CrossRef | Direct Link |
Rehni, A.K. and T.G. Singh, 2013. Pharmacological modulation of geranylgeranyltransferase and farnesyltransferase attenuates opioid withdrawal in vivo and in vitro. Neuropharmacology, 71: 19-26.
CrossRef | Direct Link |
Dhiman, S., T.G. Singh, A. Asthana and S. Arora, 2013. Solid Lipid Nanoparticles: A Current Approach to New Drug-Delivery Systems in Nanotechnology. In: Therapeutic Delivery Methods: A Concise Overview of Emerging Areas, Lee, B.J. (Ed.). Future Science Ltd., London, UK., ISBN-13: 9781909453494, pp: 110-124.
Rehni, A.K., T.G. Singh, M. Chitkara and I.S. Sandhu, 2012. Biocompatible Nanoparticle Labeling of Stem Cells and their Distribution in Brain. In: Somatic Stem Cells: Methods and Protocols, Singh, S.R. (Eds.). Chapter 33, Humana Press, Totowa, New Jersey, USA., ISBN: 978-1-61779-814-6, pp: 531-537.
Rehni, A.K., T.G. Singh and S. Arora, 2012. SU-6656, a selective Src kinase inhibitor, attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice. Nicotine Tobacco Res., 14: 407-414.
CrossRef | Direct Link |
Rehni, A.K. and T.G. Singh, 2012. Involvement of CCR-2 chemokine receptor activation in ischemic preconditioning and postconditioning of brain in mice. Cytokine, 60: 83-89.
CrossRef | Direct Link |
Dhiman, S. and T.G. Singh, 2012. Design and optimization of floating matrix tablets of famotidine by central composite design. Asian J. Pharmaceut. Clin. Res., 5: 45-49.
Direct Link |
Rehni, A.K., T.G. Singh, T. Kakkar and S. Arora, 2011. Involvement of src-kinase activation in ischemic preconditioning induced protection of mouse brain. Life Sci., 88: 825-829.
CrossRef | Direct Link |
Rehni, A.K., T.G. Singh and P. Chand, 2011. Amisulpride-induced seizurogenic effect: A potential role of opioid receptor-linked transduction systems. Basic Clin. Pharmacol. Toxicol., 108: 310-317.
CrossRef | Direct Link |
Rehni, A.K. and T.G. Singh, 2011. Modulation of leukotriene D₄ attenuates the development of seizures in mice. Prostaglandins Leukotrienes Essent. Fatty Acids, 85: 97-106.
CrossRef | Direct Link |
Dhiman, S., T.G. Singh, A.K. Rehni, S. Sood and S. Arora, 2011. Gastroretentive: A controlled release drug delivery system. Asian J. Pharm. Clin. Res., 4: 5-13.
Direct Link |
Dhiman, S., T.G. Singh and P. Pawar, 2011. Mouth dissolving tablets: As a potential drug delivery system-a review. Int. J. Pharmaceut. Sci. Rev. Res., 11: 85-95.
Direct Link |
Dhiman, S., T.G. Singh and A.K. Rehni, 2011. Transdermal patches: A recent approach to new drug delivery system. Int. J. Pharm. Pharmaceut. Sci., 3: 26-34.
Direct Link |
Rehni, A.K., T.G. Singh, P. Bhateja, N. Singh and S. Arora, 2010. Involvement of cyclic adenosine diphosphoribose receptor activation in ischemic preconditioning induced protection in mouse brain. Brain Res., 1309: 75-82.
CrossRef | PubMed | Direct Link |
Rehni, A.K., T.G. Singh, N. Singh and S. Arora, 2010. Tramadol-induced seizurogenic effect: A possible role of opioid-dependent histamine (H₁) receptor activation-linked mechanism. Naunyn-Schmiedeberg's Arch. Pharmacol., 381: 11-19.
CrossRef | Direct Link |
Rehni, A.K., T.G. Singh, N. Behl and S. Arora, 2010. Possible involvement of ubiquitin proteasome system and other proteases in acute and delayed aspects of ischemic preconditioning of brain in mice. Biol. Pharmaceut. Bull., 33: 1953-1957.
CrossRef | Direct Link |
Rehni, A.K. and T.G. Singh, 2010. Levamisole-induced reduction in seizure threshold: A possible role of nicotinic acetylcholine receptor-mediated pathway. Naunyn-Schmiedeberg's Arch. Pharmacol., 382: 279-285.
CrossRef | Direct Link |
Rehni, A.K., T.G. Singh, R. Kalra and N. Singh, 2009. Pharmacological inhibition of inducible nitric oxide synthase attenuates the development of seizures in mice. Nitric Oxide, 21: 120-125.
CrossRef | Direct Link |
Rehni, A.K., T.G. Singh, A.S. Jaggi and N. Singh, 2008. Pharmacological preconditioning of the brain: A possible interplay between opioid and calcitonin gene related peptide transduction systems. Pharmacol. Rep., 60: 904-913.
Direct Link |
Rehni, A.K., P. Bhateja, T.G. Singh and N. Singh, 2008. Nuclear factor-κ-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Behav. Pharmacol., 19: 265-269.
CrossRef | PubMed | Direct Link |